Zydus Pharmaceuticals is recalling a single lot of the drug warfarin after receiving a complaint that some of the tablets are too large.
not rated yet |
0
In the first genome-wide association study to focus on warfarin dose requirement in African-Americans, a multi-institutional team of researchers has identified a common genetic variation that can help physicians estimate ...
not rated yet |
0
Many patients who have experienced strokes or mini strokes take blood thinners such as aspirin or warfarin (Coumadin) to reduce the risk of blood clots that can cause strokes.
not rated yet |
0
A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures. The guideline is published in the May 28, 2013, ...
not rated yet |
0
As hospitals look for ways to improve patient satisfaction and boost their Medicare reimbursement, a Henry Ford Hospital study found that an inpatient pharmacist-directed anticoagulation service (PDAS) might be an unexpected ...
not rated yet |
0
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current ...
not rated yet |
0
The Journal of Neurosurgery Publishing Group is pleased to announce publication of two new studies on dabigatran etexilate (Pradaxa®) and intracranial hemorrhage: one in the Journal of Neurosurgery and the other in Neur ...
not rated yet |
0
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
not rated yet |
0
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral ...
not rated yet |
0
|
Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.
not rated yet |
0
|
(Medical Xpress)—Anticoagulants have saved the lives of those at risk for heart attack or stroke. However, because they prevent blood clotting, they can be dangerous to patients who suffer traumatic injuries or who require ...
5 / 5 (3) |
0
|
According to Dr. Samy Suissa, Director of Clinical Epidemiology, Jewish General Hospital, and Professor of Epidemiology, McGill University in Montreal, Canada, "treating physicians need to consider the clinical effectiveness ...
not rated yet |
0
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
4 / 5 (1) |
0
|
(HealthDay)—Anticoagulant use is associated with improved overall survival in men receiving docetaxel chemotherapy for treatment of metastatic castration-resistant prostate cancer (mCRPC), according to ...
not rated yet |
0
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
not rated yet |
0
